Biotechnology Halozyme Announces Upcoming Data Presentations at American Society of Hematology Annual Meeting For APOLLO and ANDROMEDA Phase 3 Studies By Janssen Evaluating Subcutaneous Daratumumab Utilizing ENHANZE® November 5, 2020
Biotechnology Fate Therapeutics Announces Twelve Presentations at the 2020 ASH Annual Meeting November 5, 2020
Biotechnology BridgeBio Pharma, Inc. Reports Third Quarter 2020 Financial Results And Business Update November 5, 2020
Biotechnology Agios Reports Business Highlights and Third Quarter 2020 Financial Results November 5, 2020
Biotechnology Amicus Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Updates November 5, 2020
Biotechnology Apellis to Present New Data Supporting the Efficacy and Safety of Pegcetacoplan in PNH at the American Society of Hematology Annual Meeting November 5, 2020
Biotechnology Axsome Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update November 5, 2020